Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Ann Med Res. 2018; 25(1): 145-147


N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease

Adil Bayramoglu.




Abstract
Cited by 0 Articles

Aim: Instent restenosis is associated with a poor outcomes in coronary artery disease patients. There are many factors and mechanisms that contribute to the development of IRS. Some of clinical trials have been shown that N-Terminal –pro Brain Nnatriuretic Peptide has an important prognostic value in coronary artery disease. we aimed to evaluate the relationship between stent restenosis and N-Terminal–pro Brain Nnatriuretic Peptide in patients of stable coronary artery disease undergo percutaneous coronary intervention.
Material and Methods: 411 patients with stent implantation due to stable coronary artery disease were evaluated and eighty patients underwent re-coronary angiography because of recurrent angına. NT-proBNP measured before coronary intervention. The patients were divided into two groups of instent restenosis developed and undeveloped.
Results: In the multivariate regression analysis; Age (OR = 1.067; 95% CI 1.002-1136, P = 0.042) and NT-proBNP (OR = 1.023, 95% CI 1.008-1.038.p = 0.002). ) have been shown that they were independent predictors of IRS. The optimal threshold NT-pro BNP value for predicting IRS was >111, with a 56.5% sensitivity and 92% specificity (area under the curve [AUC]: 0.749, 95% CI: 0.639-0.840, P

Key words: NT-Pro BNP; Coronary Artery Disease; Instent Restenosis.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.